The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months (Q44568739)

4 December 2017

title

The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months (English)

1 reference

4 December 2017

2

1 reference

4 December 2017

Frank J Vajda

1

1 reference

4 December 2017

Alison Hitchcock

series ordinal

3

1 reference

4 December 2017

Janet Graham

series ordinal

4

1 reference

4 December 2017

Cecilie Lander

series ordinal

5

1 reference

4 December 2017

publication date

1 September 2003

1 reference

Journal of Clinical Neuroscience

4 December 2017

published in

1 reference

4 December 2017

volume

10

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

543-549

1 reference

The Course and Outcome of Pregnancy in Women with Epilepsy

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Epilepsy and Pregnancy: A Report from the Oxford Record Linkage Study

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Maternal epilepsy and abnormalities of the fetus and newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: Human studies

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Pregnancy with epilepsy--a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Pregnancy and epilepsy: a retrospective study of 151 pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Congenital malformations (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Assessing epidemiological evidence for the teratogenic effects of anticonvulsant medications

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

The teratogenicity of anticonvulsant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Contemporary management of epilepsy in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Further experience of vitamin supplementation for prevention of neural tube defect recurrences

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Neural tube defects and periconceptional folic acid in England and Wales: retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Discordant expression of fetal hydantoin syndrome in heteropaternal dizygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

Family studies in fetal phenytoin exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900158-9

7 January 2021

10.1016/S0967-5868(03)00158-9

Identifiers

DOI

1 reference

4 December 2017

1 reference